Concerning Spike in Barrett's Esophagus, Esophageal Cancer in Middle-Age Adults
(MedPage Today) -- Adults in middle age showed an increasing trend of developing more Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) over the years that was not attributed to more endoscopic screening, a researcher reported. In a... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 15, 2022 Category: Hematology Source Type: news

DDW: Gallstone Disease May Predict Pancreatic Cancer Incidence
FRIDAY, May 13, 2022 -- In the year prior to pancreatic ductal adenocarcinoma (PDAC) diagnosis, patients present with gallstone disease six times more often than the general population, according to a study presented at the 2022 Digestive Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2022 Category: Pharmaceuticals Source Type: news

Could Gallstone Disease Predict Pancreatic Cancer?
(MedPage Today) -- Gallstone disease may be a red flag for pancreatic ductal adenocarcinoma (PDAC), a researcher reported. PDAC patients were diagnosed nearly three times more often with gallstone disease compared to people without cancer in the... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - May 13, 2022 Category: Gastroenterology Source Type: news

AI Tool May Help Predict Risk for Pancreatic Ductal Adenocarcinoma
MONDAY, May 2, 2022 -- An artificial intelligence tool can analyze computed tomography (CT) scans of the abdomen to predict risk for developing pancreatic ductal adenocarcinoma (PDAC), according to a study published online April 28 in Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 2, 2022 Category: Pharmaceuticals Source Type: news

Eligibility Criteria Add to Race Gap in Pancreatic Cancer Clinical Trials
THURSDAY, April 7, 2022 -- Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 22 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 7, 2022 Category: Pharmaceuticals Source Type: news

Janssen Announces Health Canada Approval of RYBREVANT ® (amivantamab), the First and Only Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Toronto, ON, April 4, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that Health Canada has issued a Notice of Compliance with Conditions (NOC/c) approving RYBREVANT® (amivantamab), a fully-human, bispecific antibody, for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating epidermal-growth factor receptor (EGFR) Exon 20 insertion mutations whose disease has progressed on or after platinum-based chemotherapy.[i] Health Canada NOC/c is granted to promising new therapies for patients diagnosed with serious, life-threate...
Source: Johnson and Johnson - April 4, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Pancreatic Cancer: Yearly Monitoring of Cystic Lesions in Doubt Pancreatic Cancer: Yearly Monitoring of Cystic Lesions in Doubt
Compared with previous research, a prospective observational study found a much lower rate of adenocarcinoma among patients with intraductal papillary mucinous neoplasms.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - March 31, 2022 Category: Primary Care Tags: Hematology-Oncology News Source Type: news

Metastasis Rate High After Resection of High-Risk Esophageal Cancers Metastasis Rate High After Resection of High-Risk Esophageal Cancers
The annual metastasis rate after radical endoscopic resection of high-risk intramucosal esophageal adenocarcinoma is nearly 7%, indicating a need for close follow-up, a retrospective study suggests.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 23, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news

Fecal Microbiota - Based Screening Feasible for Pancreatic Cancer
Fecal metagenomics classifiers better than salivary - based classifiers for identifying pancreatic ductal adenocarcinoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 9, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pathology, Journal, Source Type: news

Fecal Microbiota-Based Screening Feasible for Pancreatic Cancer
WEDNESDAY, March 9, 2022 -- Fecal microbiota-based screening seems feasible for early detection of pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 8 in Gut. Ece Kartal, Ph.D., from the European Molecular Biology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 9, 2022 Category: Pharmaceuticals Source Type: news

Pancreatic Cancer Identified by Fecal Microbiota Panel Pancreatic Cancer Identified by Fecal Microbiota Panel
A specific panel of fecal microbiota can distinguish pancreatic ductal adenocarcinoma from other high-risk disease types.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 9, 2022 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Model Using Routine Clinical Data May Predict Pancreatic Cancer Risk
MONDAY, Feb. 14, 2022 -- A model using routine clinical information can predict pancreatic ductal adenocarcinoma (PDA) following diagnosis of impaired fasting glucose (IFG), according to a study published in the January issue of the European Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 14, 2022 Category: Pharmaceuticals Source Type: news

Endometrial Cancer Characteristics and Risk of Recurrence Endometrial Cancer Characteristics and Risk of Recurrence
This study describes the clinicopathologic characteristics and survival outcomes of endometrial adenocarcinomas stratified by mismatch repair status.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 4, 2022 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

“There’s something down there…”
Discussion: Breast tissue develops from “milk lines” of the ectoderm that extend along the anterior abdominal wall from the axilla to the labia majora. While normal breast development occurs on the upper chest, breast tissue can develop anywhere along these lines. [Fallat, Greydanus] Polythelia is the presence of an accessory nipple, and is found in 1-2% of the population, and is slightly more common in males. [Greydanus] Removal can be done for cosmetic reasons should the patient desire. Polymastia or accessory breast tissue may be found as well, but is less common than polythelia alone. Like normal breast tissue, ect...
Source: EPMonthly.com - February 1, 2022 Category: Emergency Medicine Authors: Jeffrey Lyles Source Type: news